Preview

Safety and Risk of Pharmacotherapy

Advanced search

Coring of Injectable Dosage Forms: Risk Minimization Strategies (Review)

https://doi.org/10.30895/2312-7821-2026-541

Abstract

INTRODUCTION. Contamination of injection and infusion preparations in the vials with fragments of a punctured stopper (coring) poses direct risks of microembolism, inflammatory reactions in patients, and dosing errors. No risk minimization strategy for coring of a punctured stopper currently exists in the Russian Federation.

AIM. This study aimed to determine the ways to minimize contamination risk of an injectable drug with particles of a vial stopper punctured by a needle.

DISCUSSION. Standardized puncturing technique for vial stoppers was found to be a fundamental preventative measure: puncturing at an angle of 45–60º, followed by a right angle, with the bevel facing upwards, significantly reduces the risk of a fragmented stopper. Using small-gauge needles (≥20G) and restricting the number of punctures (as few as possible and at least 0.75 mm apart) also minimized coring. Filter needles that trap the resulting particles were substantiated as a reliable technological solution, as well as choosing closed-loop transfer systems and prefilled single-use syringes that prevents any stopper manipulations. The important elements of the strategy include a thorough visual inspection of each dose against a dark background under intense light and training medical personnel to puncture the vials using simulation techniques.

CONCLUSIONS. Based on the references, the strategy offered to minimize the risks associated with the vial stopper fragmentation at injection and infusion integrates technological, methodological, and organizational solutions. For practical implementation, it is recommended to standardize the puncturing technique of the vial stopper; to train medical personnel in puncturing techniques that reduce the risk of forming stopper particles; to visually inspect each dose of the drug before administration; and to use specific medical devices that prevent manipulations with the vial stopper.

About the Authors

M. A. Yaroshinsky
Pharm-Sintez JSC
Russian Federation

Milan A. Yaroshinsky

29/134 Vereyskaya St., Moscow 121357



M. V. Andreeva
Pharm-Sintez JSC
Russian Federation

Maria V. Andreeva

29/134 Vereyskaya St., Moscow 121357



D. G. Kinasov
Pharm-Sintez JSC
Russian Federation

Dmitry G. Kinasov, Cand. Sci. (Pharm.)

29/134 Vereyskaya St., Moscow 121357



E. I. Balakin
Pharm-Sintez JSC
Russian Federation

Evgenii I. Balakin, Cand. Sci. (Med.)

29/134 Vereyskaya St., Moscow 121357



A. Yu. Savchenko
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
Russian Federation

Alla Yu. Savchenko, Cand. Sci. (Med.)

31 Kashirskoe Hwy, Moscow 115409



E. A. Tsareva
Pharm-Sintez JSC
Russian Federation

Ekaterina A. Tsareva

29/134 Vereyskaya St., Moscow 121357



O. A. Ivanova
Pharm-Sintez JSC
Russian Federation

Olga A. Ivanova

29/134 Vereyskaya St., Moscow 121357



V. I. Pustovoit
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Russian Federation

Vasily I. Pustovoit, Dr. Sci. (Med.)

46 Zhivopisnaya St., Moscow 123098



References

1. Hruska JL, Saasouh W, Alhamda MS. Coring revisited: A case report and literature review. Cureus. 2022;14(9):e29750. https://doi.org/10.7759/cureus.29750

2. Eskander J, Cotte J, Glenn E, et al. The incidence of coring and fragmentation of medication vial rubber stoppers. J Clin Anesth. 2015;27(5):442–4. https://doi.org/10.1016/j.jclinane.2015.01.009

3. Kordi R, White BF, Kennedy DJ. Possibility and risk of medication vial coring in interventional spine procedures. PM R. 2017;9(3):289–93. https://doi.org/10.1016/j.pmrj.2016.09.003

4. Chotikawanich T, Kammee T, Khantee S. The impact of needle size and angle on rubber coring after multiple puncturing of multi-dose propofol vial rubber stoppers. Heliyon. 2022;8(5):e09389. https://doi.org/10.1016/j.heliyon.2022.e09389

5. Mateen MA, Dwivedi D, De A, Haldar A. Fragmentation and coring of a vial — An avoidable threat. Indian J Anaesth. 2023;67(10):945–7. https://doi.org/10.4103/ija.ija_941_22

6. Stein HA, Vu BL. Coring: a potential problem in eye surgery. J Cataract Refract Surg. 1994;20(2):169–71. https://doi.org/10.1016/s0886-3350(13)80159-9

7. Asakura T. Research regarding proper use of insulin in diabetes patients. Yakugaku Zasshi. 2001;121(9):653–61 (In Japanese). https://doi.org/10.1248/yakushi.121.653

8. van den Berg RB, Ganesh M, Crul M, et al. Examination of particulate contamination in parenteral injections and infusions following fluid withdrawal utilizing conventional needles and filter needles: Assessment of compliance and comparative analysis. J Pharm Sci. 2024;113(9):2668–74. https://doi.org/10.1016/j.xphs.2024.05.031

9. van den Berg RB, Serbée-Wijker E, Westerman EM, et al. Particulate contamination in parenteral fluid from glass ampoules: Compliance assessment and comparative analysis of needle types and ampoule-breaking strategies. Eur J Pharm Sci. 2025;212:107184. https://doi.org/10.1016/j.ejps.2025.107184

10. Roth JV. How to enter a medication vial without coring. Anesth Analg. 2007;104(6):1615. https://doi.org/10.1213/01.ane.0000260552.76585.53

11. Wani T, Wadhwa A, Tobias JD. The incidence of coring with blunt versus sharp needles. J Clin Anesth. 2014;26(2):152–4. https://doi.org/10.1016/j.jclinane.2013.10.007

12. Chennell P, Bourdeaux D, Citerne Q, et al. Rubber coring of injectable medication vial stoppers: An evaluation of causal factors. Pharm Technol Hosp Pharm. 2016;1(4). https://doi.org/10.1515/pthp-2016-0015

13. Campagna R, Pessis E, Guerini H, et al. Occurrence of coring after needle insertion through a rubber stopper: Study with prednisolone acetate. Eur Radiol. 2013;23(2):424–7. https://doi.org/10.1007/s00330-012-2602-3

14. Ali FS, Schneider EW, Arepalli S, et al. Coring of intravitreal medication vial stoppers: A report from the research in safety and therapeutics committee of the American Society of Retina Specialists. J Vitreoretinal Dis. 2025;24741264251356296. https://doi.org/10.1177/24741264251356296

15. Chanana GD, Guo X, Avis KE, et al. Evaluation of closure integrity after multiple penetrations. J Parenter Sci Technol. 1993;47(1):22–5. PMID: 8445495

16. Inoue T, Yamamoto T. Adrenaline dilution in dental local anesthetic: A preliminary study to prevent coring in cartridges. J Dent Anesth Pain Med. 2024;24(6):415–20. https://doi.org/10.17245/jdapm.2024.24.6.415

17. Hutin Y, Hauri A, Chiarello L, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003;81(7):491–500. PMID: 12973641

18. Montero JA, Ruiz-Moreno JM, Sanchis-Merino E. Intravitreal ranibizumab, with or without filter? Acta Ophthalmol. 2012;90(5):e405–6. https://doi.org/10.1111/j.1755-3768.2011.02278.x

19. Henretig FM, Mechem C, Jew R. Potential use of autoinjector-packaged antidotes for treatment of pediatric nerve agent toxicity. Ann Emerg Med. 2002;40(4):405–8. https://doi.org/10.1067/mem.2002.126779

20. Wilkinson AS, Walker KE, Ozolina L, et al. Integrity performance assessment of a closed system transfer device syringe adaptor lock as a terminal closure for Luer–Lock syringes. Eur J Hosp Pharm. 2023;31(1):50–6. https://doi.org/10.1136/ejhpharm-2021-003148

21. Bello W, Pezzatti J, Rudaz S, Sadeghipour F. Study of leachable compounds in hospital pharmacy-compounded prefilled syringes, infusion bags and vials. J Pharm Sci. 2024;113(11):3227–37. https://doi.org/10.1016/j.xphs.2024.08.004

22. Ingle RG, Fang WJ. Prefilled dual chamber devices (DCDs) — Promising high-quality and convenient drug delivery system. Int J Pharm. 2021;597:120314. https://doi.org/10.1016/j.ijpharm.2021.120314

23. Nickel B, Gorski L, Kleidon T, et al. Infusion therapy standards of practice, 9th edition. J Infus Nurs. 2024;47(1S):S1–285. https://doi.org/10.1097/nan.0000000000000532


Review

For citations:


Yaroshinsky M.A., Andreeva M.V., Kinasov D.G., Balakin E.I., Savchenko A.Yu., Tsareva E.A., Ivanova O.A., Pustovoit V.I. Coring of Injectable Dosage Forms: Risk Minimization Strategies (Review). Safety and Risk of Pharmacotherapy. 2026;14(2):207-215. (In Russ.) https://doi.org/10.30895/2312-7821-2026-541

Views: 261

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)